Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
AVEO Pharmaceuticals Inc.
AVEO
Healthcare
Biotechnology
AVEO Pharmaceuticals Inc is a commercial-stage, oncology-focused biopharmaceutical company engaged in offering medicines that provide a better life for patients with cancer. The company markets FOTIVDA (tivozanib) in the United States.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:AVEO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(668)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Jun 03, 2019 10:49am
watching this one for
an entry point,so glta.
(668)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Apr 24, 2019 8:30pm
still watching & still waiting
to get an entry point for me,so glta.
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(0)
•••
Money pit
X
View Profile
View Bullboard History
Post by
Money pit
on Apr 09, 2019 4:05pm
Good article from zacks about AVEO
https://www.zacks.com/stock/news/372704/aveo-pharmaceuticals-aveo-outpaces-stock-market-gains-what-you-should-know
(0)
•••
Money pit
X
View Profile
View Bullboard History
Comment by
Money pit
on Apr 04, 2019 8:28am
RE:watching this one and
Good question honestly...since the 2 April the stock is in free fall and I thought it would be a bit more stability with this stock after the result of clinical trial
(668)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Apr 03, 2019 10:57am
watching this one and
wondering if the bottom is in and then I will decide if it is worth buying it,so glta.
(668)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Feb 19, 2019 10:42am
it's a sell today for me
the pharma and biotech stocks are really tough sometimes,so glta shareholders left here,but it is time to take my losses from this stock.
(0)
•••
ARNULF
X
View Profile
View Bullboard History
Comment by
ARNULF
on Jan 15, 2019 2:01am
RE:it's a buy today for me
I think this is a great trading stock. Easy buy when it hit the 1.60 area. Surprised it stalled out at the 2 range. But like I said before this management I crooks and a big factor in these peaks and
...more
(668)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Nov 26, 2018 2:25pm
it's a buy today for me
at the $2.15 per share it is looking like a good one for me to hold and when others are selling it is time to do some buying,so glta.
(19)
•••
mevani
X
View Profile
View Bullboard History
Comment by
mevani
on Sep 26, 2018 9:53am
RE:RE:RE:RE:RE:I'm out
I hope you got back in on time. The confrence is coming up and I think we may see more upside. At least I hope. I am still holding here
(0)
•••
ARNULF
X
View Profile
View Bullboard History
Comment by
ARNULF
on Sep 25, 2018 6:23pm
RE:RE:RE:RE:I'm out
SH!t!!!!!!!!
(0)
•••
ARNULF
X
View Profile
View Bullboard History
Comment by
ARNULF
on Sep 16, 2018 10:19am
RE:RE:RE:I'm out
Still waiting for entry point. This mgmt has me scared to to buy now lol I still think the crooks will try and sink it again and buy on the cheep. The 255 event is said to becoming soon so I'll
...more
(0)
•••
ARNULF
X
View Profile
View Bullboard History
Comment by
ARNULF
on Sep 09, 2018 9:52am
RE:RE:I'm out
I’ll be getting back in this week. It’s trading good plus I was kicking myself but now it’s gone below where I sold at lol. But hey you take a look at ONCY because this week it might have lift off so
...more
(19)
•••
mevani
X
View Profile
View Bullboard History
Comment by
mevani
on Sep 06, 2018 6:03pm
RE:I'm out
I am still in. I have increased my holdings. Greed is a bad thing. Lol
(0)
•••
ARNULF
X
View Profile
View Bullboard History
Post by
ARNULF
on Aug 30, 2018 10:32pm
I'm out
K great made a few bucks. I wish I could trade better because this is a day traders dream. Anyways expecting pull back tomorrow so if it's a good one I may buy before close. Later
(0)
•••
ARNULF
X
View Profile
View Bullboard History
Comment by
ARNULF
on Aug 26, 2018 10:24am
RE:RE:Excellent
Happy I’m in the green. Now where to sell ? This mgmt are a bunch of crooks so I bet they pull some sh!t again to buy shares on the cheep just like the offering
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover a Green Resources Stock Scoring Record Quarterly Growth
Stage Set for Creation of a Leading Intermediate Gold Producer
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study